2 ,
暂无分享,去创建一个
Andreas K. Engel | Ulrich G. Hofmann | Kerstin M. L. Menne | C. K. E. Moll | S. Kondra | M. Bär | P. Detemple | P. Steerenberg | J. Hendriks | L. Dekker | Qgcm van HoeseP | D. Crommelin | G. Storm
[1] Richard M. Marks,et al. Undertreatment of Medical Inpatients with Narcotic Analgesics , 1973 .
[2] B. Ferrell,et al. Nurses' knowledge of pain assessment and management: how much progress have we made? , 1997, Journal of pain and symptom management.
[3] M. Austrup,et al. Analgesic agents for the postoperative period. Opioids. , 1999, The Surgical clinics of North America.
[4] E. T. Herfindal,et al. Textbook of Therapeutics: Drug and Disease Management , 2000 .
[5] Richard A. Helms,et al. Textbook of therapeutics : drug and disease management , 2006 .
[6] J. Furth,et al. Direct Determinations of Plasma, Cell, and Organ-Blood Volumes in Normal and Hypervolemic Mice , 1950, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[7] The husbandry of mice with congenital absence of the thymus (nude mice). , 1974, Zeitschrift fur Versuchstierkunde.
[8] O. Stein,et al. Biological stability of [3H]cholesteryl oleyl ether in cultured fibroblasts and intact rat , 1980, FEBS letters.
[9] R. Ozols,et al. Phase I and Pharmacological Studies of Adriamycin Administered Intraperitoneally to Patients with Ovarian Cancer , 1982, Cancer research.
[10] J. Whang‐Peng,et al. Characterization of a human ovarian carcinoma cell line (NIH:OVCAR-3) with androgen and estrogen receptors. , 1983, Cancer research.
[11] R. Ozols,et al. Characterization of a xenograft model of human ovarian carcinoma which produces ascites and intraabdominal carcinomatosis in mice. , 1984, Cancer research.
[12] D. Wessel,et al. A method for the quantitative recovery of protein in dilute solution in the presence of detergents and lipids. , 1984, Analytical biochemistry.
[14] R. Knapp,et al. Localization of radiolabelled F(ab′)2 fragments of monoclonal antibodies in nude mice bearing intraperitoneally growing human ovarian cancer xenografts , 1988, International journal of cancer.
[15] D. Papahadjopoulos,et al. Liposome-based therapy of human ovarian cancer: parameters determining potency of negatively charged and antibody-targeted liposomes. , 1988, Cancer research.
[16] Aquilur Rahman,et al. A phase I/II study of intraperitoneally administered doxorubicin entrapped in cardiolipin liposomes in patients with ovarian cancer. , 1989, American journal of obstetrics and gynecology.
[17] J. Lewis,et al. Intraperitoneal therapy in the management of ovarian carcinoma. , 1989, The Yale journal of biology and medicine.
[18] Gunnar von Heijne,et al. In sequence , 1989, Nature.
[19] D. Scudiero,et al. New colorimetric cytotoxicity assay for anticancer-drug screening. , 1990, Journal of the National Cancer Institute.
[20] P. Kenemans,et al. Comparative in vitro binding characteristics and biodistribution in tumor-bearing athymic mice of anti-ovarian carcinoma monoclonal antibodies. , 1990, Anticancer research.
[21] M. Markman. Intraperitoneal chemotherapy. , 1991, Seminars in oncology.
[22] K. Maruyama,et al. Enhanced delivery of doxorubicin to tumor by long-circulating thermosensitive liposomes and local hyperthermia. , 1993, Biochimica et biophysica acta.
[23] Francis C. Szoka,et al. pH-Sensitive Liposomes , 1994 .